Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell Responses to Extracellular α-Synuclein
Alexei Surguchev, Fatemeh Nouri Emamzadeh, Andrei Surguchov
Molecules (2019) Vol. 24, Iss. 2, pp. 305-305
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Prion-Like Mechanisms in Parkinson’s Disease
Jiangnan Ma, Jing Gao, Jing Wang, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 117
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Jacob Deyell, Manjari Sriparna, Mingyao Ying, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2477-2477
Open Access | Times Cited: 33
From Synaptic Physiology to Synaptic Pathology: The Enigma of α-Synuclein
Kaja Nordengen, Cecilie Morland
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 986-986
Open Access | Times Cited: 10
Interactions of α-synuclein oligomers with lipid membranes
Greta Musteikytė, Akhila K. Jayaram, Catherine K. Xu, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2020) Vol. 1863, Iss. 4, pp. 183536-183536
Open Access | Times Cited: 61
Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
Andrei Surguchov, Fatemeh Nouri Emamzadeh, Mariya Titova, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 19
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives
Tizibt Ashine Bogale, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
Kuo‐Hsuan Chang, Mei‐Ling Cheng, Hsiang-Yu Tang, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 395-395
Open Access | Times Cited: 27
The neuroprotective effect of human umbilical cord MSCs-derived secretome against α-synuclein aggregates on the blood-brain barrier
Kimia Marzookian, Farhang Aliakbari, Hamdam Hourfar, et al.
International Journal of Biological Macromolecules (2025), pp. 140387-140387
Closed Access
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Biology (2020) Vol. 9, Iss. 4, pp. 86-86
Open Access | Times Cited: 32
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells
Changyoun Kim, Somin Kwon, Michiyo Iba, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 2, pp. 281-290
Open Access | Times Cited: 30
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
Andrei Surguchov
Cells (2021) Vol. 10, Iss. 2, pp. 407-407
Open Access | Times Cited: 30
Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
Emil Gregersen, Cristine Betzer, Woojin S. Kim, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 28
Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
Xinchao Hu, Chengyuan Mao, Liyuan Fan, et al.
Stem Cells International (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 28
Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson’s Disease
David J. Rademacher
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1187-1187
Open Access | Times Cited: 10
The Synucleins and the Astrocyte
Abigail J. Myers, Ayat Brahimi, Imani J. Jenkins, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 155-155
Open Access | Times Cited: 8
Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta‐analysis
Hash Brown Taha, Aleksander Bogoniewski
Journal of Extracellular Biology (2023) Vol. 2, Iss. 11
Open Access | Times Cited: 8
Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
Jacqui Nimmo, David A. Johnston, Jean‐Cosme Dodart, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Chaperones and Proteostasis: Role in Parkinson’s Disease
Neha Joshi, Atchaya Raveendran, Shirisha Nagotu
Diseases (2020) Vol. 8, Iss. 2, pp. 24-24
Open Access | Times Cited: 16
Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in Drosophila
Jean-Noël Arsac, Marianne Sedru, Mireille Dartiguelongue, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11613-11613
Open Access | Times Cited: 14
Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models
Attila Lehotzky, Judit Oláh, János Tibor Fekete, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 13
Sustained Neurotrophin Release from Protein Nanoparticles Mediated by Matrix Metalloproteinases Induces the Alignment and Differentiation of Nerve Cells
Yuka Matsuzaki, Rina Maruta, Keiko Takaki, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 510-510
Open Access | Times Cited: 14
Regulation of Mitochondrial Dynamics in Parkinson’s Disease—Is 2-Methoxyestradiol a Missing Piece?
Paulina Bastian, Jarosław Dulski, Anna Roszmann, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 248-248
Open Access | Times Cited: 12
Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease
Zeynep Bengisu Kaya, Elif Karakoç, Pamela J. McLean, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 7, pp. 263-276
Open Access | Times Cited: 4
The Sherpa hypothesis: Phenotype-Preserving Disordered Proteins stabilize the phenotypes of neurons and oligodendrocytes
Victor Norris, Judit Oláh, Sergey N. Krylov, et al.
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
Karen M. Delgado-Minjares, Daniel Martínez‐Fong, Irma A. Martínez‐Dávila, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11702-11702
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top